Context The unprecedented health care scenario caused by the coronavirus disease 2019
(COVID-19) pandemic has revolutionized urology practice worldwide. Objective To review …

Assessment of Patients with Hematuria Hematuria comes in two main varieties: gross and
microscopic. A wide range of ailments can lead to hematuria, and the central task is to rule …

Background Hematuria can be either grossly visible (macrohematuria) or only detectable
under a microscope (microhematuria). Microhematuria is often asymptomatic and has a …

Purpose: Computerized tomography urogram is recommended when investigating patients
with hematuria. We determined the incidence of urinary tract cancer and compared the …

Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer,
upper tract urothelial cancer [UTUC] and renal cancer) in patients referred to secondary care …

Background Urinary biomarkers for the diagnosis of bladder cancer represents an area of
considerable research which has been tested in both patients presenting with haematuria …

Background Patients with metastatic bladder cancer have very poor prognosis and
predictive biomarkers are urgently needed for early clinical detection and intervention. In this …

Context Non-visible haematuria (NVH) is a common finding and may indicate undiagnosed
urological cancer. The optimal investigation of NVH is unclear, given the incidence of cancer …

Background Patient factors associated with urinary tract cancer can be used to risk stratify
patients referred with haematuria, prioritising those with a higher risk of cancer for prompt …

Purpose: Urinary comprehensive genomic profiling (uCGP) uses next-generation
sequencing to identify mutations associated with urothelial carcinoma and has the potential …